Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

FDA Approves Makenaâ„¢, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm ...

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Feb. 4, 2011 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company"), a specialty pharmaceutical company, announced today that it has been informed by Hologic, Inc. that the U.S. Food and Drug Administration (FDA) granted approval for Makena™ (hydroxyprogesterone...

TOPICS:

FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Feb. 4, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one...

TOPICS:

FDA Approves Hologic's Makenaâ„¢ (Formerly Referred to as Gestivaâ„¢) Pharmaceutical

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., Feb. 4, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the...

TOPICS:
Advertisement

Novo Nordisk Creates First Mobile Application to Help Doctors Diagnose Bleeding Disorders

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Feb. 4, 2011 /- Novo Nordisk announced today the availability of Coags Uncomplicated – the first mobile application (app) to assist in the diagnosis of bleeding disorders – created in partnership with Craig Kessler, MD, Professor of Medicine and Pathology and...

TOPICS:

WebMD to Present at the UBS 21st Annual Global Healthcare Services Conference

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 4, 2011 /- WebMD Health Corp. (Nasdaq: WBMD ) today announced that Wayne Gattinella, President and CEO, will deliver a presentation at the UBS 21st Annual Global Healthcare Services Conference on Tuesday, February 8, 2011 at 12:00 p.m. ET. Investors, analysts and the...

TOPICS:

Aetna's 4Q profit jumps 30 percent(2)

February 4, 2011 1:46 am | by The Associated Press | News | Comments

Health insurer Aetna says its fourth-quarter net income rose 30 percent as it benefited from higher pricing and a slowdown in health care use that also has helped its competitors.The Hartford, Conn., insurer said Friday it earned $215.6 million, or 53 cents per share, in the three months that...

Aetna's 4Q profit jumps 30 percent

February 4, 2011 1:46 am | News | Comments

Health insurer Aetna says its fourth-quarter net income rose 30 percent as it benefited from higher pricing and a slowdown in health care use that also has helped its competitors.The Hartford, Conn., insurer said Friday it earned $215.6 million, or 53 cents per share, in the three months that...

FDA Grants Orphan Drug Designation to Bayer's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors

February 4, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

WAYNE, N.J., Feb. 4, 2011 /- Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumors (GIST) by the U.S. Food and Drug...

TOPICS:
Advertisement

Family mealtimes play a role in health of children with asthma

February 3, 2011 8:33 pm | by EurekAlert | News | Comments

(Society for Research in Child Development) Researchers studying 200 families with children ages 5-12 who had persistent asthma observed how they interacted during a video-recorded meal in their homes. They found that the quality of social interactions as families ate was directly related...

TOPICS:

Report says economic development could change worldwide face of cancer

February 3, 2011 8:33 pm | by EurekAlert | News | Comments

(American Cancer Society) A new American Cancer Society report says cancers associated with lifestyles and behaviors related to economic development, including lung, breast, and colorectal cancers, will continue to rise in developing countries if preventive measures are not widely applied.

TOPICS:

Researchers "Grow" New Blood Vessels

February 3, 2011 7:32 pm | by Massachusetts Institute of Technology | News | Comments

The synthetic vessels can be stored for long periods and avoid the complications typical of vessel grafts.

TOPICS:

CareFusion 2Q profit rises, company pares outlook

February 3, 2011 5:45 pm | by The Associated Press | News | Comments

Medical device maker CareFusion Corp. said Thursday its profit increased 9 percent in the fiscal second quarter as cost cuts offset a decline in sales.The company said its profit rose to $76 million, or 34 cents per share, from $70 million, or 32 cents per share. Excluding items like...

FDA sued over shipments of drug used in executions

February 3, 2011 12:45 pm | by GREG BLUESTEIN - Associated Press - Associated Press | News | Comments

A federal lawsuit filed against the Food and Drug Administration urges a judge to block overseas shipments of a key drug used in the nation's executions that has been in short supply since the sole U.S. maker decided to stop producing it.The lawsuit filed Wednesday in federal court in Washington,...

US agency sued over drug used in executions

February 3, 2011 12:45 pm | by GREG BLUESTEIN - Associated Press - Associated Press | News | Comments

A federal lawsuit filed against the Food and Drug Administration urges a judge to block overseas shipments of a key drug used in the nation's executions that has been in short supply since the sole U.S. maker decided to stop producing it.The lawsuit filed Wednesday in federal court in...

Using a generic blood pressure and heart drug could save the UK $324 million in 2011

February 3, 2011 12:38 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) Using a generic drug to treat hypertension and heart failure, instead of branded medicines from the same class, could save the UK's National Health Service at least £200 ($324) million in 2011 without any real reduction in clinical benefits. That is the key...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading